IXI Ixico Plc

TIDMIXI

RNS Number : 4530V

IXICO plc

30 January 2017

30 January 2017

IXICO plc

("IXICO" or the "Company")

Results of AGM

IXICO plc (AIM: IXI), the brain health company, today announces that that all resolutions put to its Annual General Meeting held earlier today were duly passed.

For further information please contact:

 
 IXICO plc 
 Susan Lowther, Chief Financial Officer 
 and Company Secretary Tel: +44 20 
 3763 7499 
 Shore Capital (Nomad and Broker) 
  Bidhi Bhoma / Edward Mansfield Tel: 
  +44 20 7408 4090 
 
 FTI Consulting Limited (Investor 
  Relations) 
  Simon Conway/Mo Noonan/Matthew Moss 
  Tel: +44 20 3727 1000 
 
 

About IXICO

IXICO's innovative and proprietary digital healthcare technologies help those involved in researching and treating serious diseases to capture and analyse clinical data to make rapid, informed decisions. In clinical research this includes the phenotyping of patients, quantification of disease pathology and measurement of patient outcomes. In clinical practice the mobile health and digital decision support technologies aid diagnosis, patient engagement and monitoring. IXICO is also collaborating with partners to develop companion digital health products targeted at improving patient outcomes.

The Company's brain health focus includes Alzheimer's disease, Huntington's disease, multiple sclerosis, Parkinson's disease, behavioural health, child and adolescent mental health.

More information is available on www.ixico.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGOKKDBKBKDKDN

(END) Dow Jones Newswires

January 30, 2017 05:28 ET (10:28 GMT)

Ixico (LSE:IXI)
Historical Stock Chart
From Apr 2024 to May 2024

Ixico (LSE:IXI)
Historical Stock Chart
From May 2023 to May 2024